AbbyRRosenbergMDMS, MA

Pediatric Hematology & Oncology • Boston, MA

Associate Professor, Pediatrics, Harvard Medical School

Join to view full profile

Dr. Rosenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rosenberg's full profile

Already have an account?

Office
450 Brookline Ave
# JFB7
Boston, MA 02215
Phone+1 617-632-3000

Education & Training

University of WashingtonResidency, Pediatrics, 2006 - 2009
Stanford University School of MedicineClass of 2006
University of WashingtonFellowship, Pediatric Hematology/Oncology

Certifications & Licensure

MA State Medical License 2022 - 2025
WA State Medical License 2006 - 2024
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors Start of enrollment: 2013 Dec 01
Unknown status
Not Applicable
A Pilot RCT of the PRISM Intervention for AYAs With Cancer Start of enrollment: 2015 Jan 30
Completed
Phase 2
PRISM for Parents of Children With Cancer Promoting Resilience in Stress Management (PRISM) Intervention for Parents of Children With Cancer Start of enrollment: 2016 Dec 05
Completed
Not Applicable
The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation Start of enrollment: 2019 Apr 01
Active, not recruiting
Phase 3
The PediQUEST Response Intervention Study Start of enrollment: 2018 Mar 01
Completed
Not Applicable
Roles: Contact, Principal Investigator
The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer Start of enrollment: 2019 Apr 15
Active, not recruiting
Not Applicable
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

37 citations
Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: A report from the Children’s Onco...
Abby R. Rosenberg, James R. Anderson, Elizabeth Lyden, David A. Rodeberg, Suzanne L. Wolden
European Journal of Cancer. 2014-03-01
21 citations
Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
Abha A. Gupta, Yueh-Yun Chi, James R. Anderson, Elizabeth Lyden, Brenda J. Weigel
Pediatric Blood & Cancer. 2017-03-23
5 citations
Parent Perceptions of Team-Delivered Care for Children With Advanced Cancer: A Report From the PediQUEST Study
Angela M. Feraco, Prasanna Ananth, Veronica Dussel, Hasan Al-Sayegh, Clement Ma
Journal of Pain and Symptom Management. 2020-10-01

Lectures

Novel Approaches to Enhance the Educational Process and Improve Patient Engagement
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
Hope and benefit-finding among adolescents and young adults with cancer: Results from the PRISM randomized controlled trial.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

Leader in Pediatric Oncology Receives National Honor from American Cancer SocietyJune 30th, 2022
We, TooApril 28th, 2019
When Young People Survive Cancer, Their Mental-Health Struggles Are Often Just BeginningJune 29th, 2023